- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.13 Å
- Oligo State
- monomer
- Ligands
- 1 x NRE: [(2~{S},5~{S})-2-[[(5-bromanylpyridin-2-yl)amino]methyl]-5-methyl-piperidin-1-yl]-(3-fluoranyl-2-methoxy-phenyl)methanone(Non-covalent)
- 2 x SO4: SULFATE ION(Non-functional Binders)
- 2 x PGW: (1R)-2-{[(S)-{[(2S)-2,3-dihydroxypropyl]oxy}(hydroxy)phosphoryl]oxy}-1-[(hexadecanoyloxy)methyl]ethyl (9Z)-octadec-9-enoate(Non-covalent)
PGW.4: 11 residues within 4Å:- Chain A: S.114, L.118, V.198, G.205, L.206, M.209, A.210, Q.213, R.216
- Ligands: PGW.5, SOG.12
7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:L.118, A:L.206, A:L.206, A:M.209, A:A.210, A:Q.213
- Hydrogen bonds: A:Q.213
PGW.5: 19 residues within 4Å:- Chain A: A.150, I.151, M.152, V.153, P.154, A.157, V.158, R.181, W.182, A.183, D.184, A.187, I.190, Y.191, C.194, F.195, V.198
- Ligands: PGW.4, SOG.8
14 PLIP interactions:14 interactions with chain A- Hydrophobic interactions: A:A.150, A:I.151, A:I.151, A:V.153, A:P.154, A:W.182, A:Y.191, A:Y.191, A:Y.191, A:F.195, A:V.198
- Hydrogen bonds: A:A.157, A:A.183, A:D.184
- 15 x SOG: octyl 1-thio-beta-D-glucopyranoside(Non-covalent)
SOG.6: 5 residues within 4Å:- Chain A: L.168, R.171, T.172, R.173, F.175
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:F.175
- Hydrogen bonds: A:T.172, A:T.172, A:R.173
- Water bridges: A:A.174
SOG.7: 3 residues within 4Å:- Chain A: F.90, L.94, R.173
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:R.173, A:R.173
SOG.8: 6 residues within 4Å:- Chain A: K.96, Y.100, V.153, A.156, A.157
- Ligands: PGW.5
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:Y.100, A:Y.100, A:V.153
SOG.9: 4 residues within 4Å:- Chain A: K.189, V.267, F.268
- Ligands: SOG.18
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:K.189, A:K.189
- Water bridges: A:R.272
SOG.10: 6 residues within 4Å:- Chain A: L.256, P.257, V.260, L.261, L.264, M.270
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:L.261, A:L.264
SOG.11: 5 residues within 4Å:- Chain A: K.265, V.280, Y.281, F.284, H.288
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:Y.281, A:F.284, A:F.284, A:F.284
SOG.12: 9 residues within 4Å:- Chain A: F.115, R.136, G.139, S.140, G.143, I.144, V.147
- Ligands: PGW.4, SOG.16
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:V.147
SOG.13: 5 residues within 4Å:- Chain A: V.35, V.38, N.303, F.313, F.317
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:V.35, A:V.38, A:N.303, A:F.313, A:F.317
SOG.14: 3 residues within 4Å:- Chain A: E.86, S.87, A.174
No protein-ligand interaction detected (PLIP)SOG.15: 2 residues within 4Å:- Chain A: C.125, H.126
No protein-ligand interaction detected (PLIP)SOG.16: 8 residues within 4Å:- Chain A: F.115, L.118, D.119, Y.122, A.123, F.130, S.132
- Ligands: SOG.12
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:L.118, A:Y.122, A:Y.122
SOG.17: 4 residues within 4Å:- Chain A: Q.222, P.224, G.225, T.226
5 PLIP interactions:5 interactions with chain A- Hydrogen bonds: A:I.223, A:G.225, A:T.226, A:T.226, A:T.226
SOG.18: 2 residues within 4Å:- Chain A: F.268
- Ligands: SOG.9
No protein-ligand interaction detected (PLIP)SOG.19: 6 residues within 4Å:- Chain A: Y.211, F.212, F.215, M.245, V.248
- Ligands: SOG.20
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:Y.211, A:V.248
SOG.20: 7 residues within 4Å:- Chain A: F.215, W.219, K.242, M.245, V.246, L.249
- Ligands: SOG.19
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:K.242, A:M.245, A:V.246, A:L.249
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Rappas, M. et al., Comparison of Orexin 1 and Orexin 2 Ligand Binding Modes Using X-ray Crystallography and Computational Analysis. J.Med.Chem. (2020)
- Release Date
- 2020-01-15
- Peptides
- Orexin receptor type 1: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
B - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.13 Å
- Oligo State
- monomer
- Ligands
- 1 x NRE: [(2~{S},5~{S})-2-[[(5-bromanylpyridin-2-yl)amino]methyl]-5-methyl-piperidin-1-yl]-(3-fluoranyl-2-methoxy-phenyl)methanone(Non-covalent)
- 2 x SO4: SULFATE ION(Non-functional Binders)
- 2 x PGW: (1R)-2-{[(S)-{[(2S)-2,3-dihydroxypropyl]oxy}(hydroxy)phosphoryl]oxy}-1-[(hexadecanoyloxy)methyl]ethyl (9Z)-octadec-9-enoate(Non-covalent)
- 15 x SOG: octyl 1-thio-beta-D-glucopyranoside(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Rappas, M. et al., Comparison of Orexin 1 and Orexin 2 Ligand Binding Modes Using X-ray Crystallography and Computational Analysis. J.Med.Chem. (2020)
- Release Date
- 2020-01-15
- Peptides
- Orexin receptor type 1: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
B - Membrane
-
We predict this structure to be a membrane protein.